Teri Foy, Ph.D, is the Senior Vice President of Research and Early Development, Immuno-Oncology and Cell Therapy at Bristol Myers Squibb (BMS). In her role, Teri oversees a team of researchers working tirelessly on translating scientific advances in immune effector cell-based therapies into treatments for hematological and solid cancers.
Dr. Teresa (Teri) Foy, PhD
“We take a look at these unmet medical needs in the community and think about strategies to meet them.”
Teri has years of experience in the biopharmaceutical industry working to develop and improve novel therapeutics in the areas of oncology and inflammation. Outside of the workplace, Teri is a passionate supporter of women in STEM and actively participates in a number of initiatives to help women with their career development. In 2020, Teri received the Healthcare Businesswomen’s Association Luminary award for her work to support the careers of women in the healthcare industry.
Recently, Teri was featured in an Axios piece that highlighted her work in the future of cell therapies in treating blood disorders. Watch the full video below.
Ready to Get Involved?
Make your voice heard to protect innovation.